Childhood leukemia can be reversed by switching on the Pax5 gene

Researchers recently discovered that switching on the expression of Pax5, a tumor suppressor gene commonly mutated in childhood leukemia patients, was sufficient to reverse leukemia.

Will this success stimulate a greater emphasis on genetic approaches to curing cancer?
Follow hot news stories and seminal publications in the fields of genetic engineering, synthetic biology, gene therapy, and exciting new applications for gene synthesis across all disciplines of life science. Check this page weekly for featured stories curated by our Ph.D. technical writers, accompanied by the background info you need to understand how trending technologies can inform your research.